Daulong, Markclent .
HRN: 23-00-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2023
AMPICILLIN 250MG (VIAL)
05/07/2023
05/13/2023
IV
100
Q12
SEPSIS NEONATARUM
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes